Use of aromatase inhibitors for up to 3 years in combination with growth hormone may be an effective and safe option to help very short adolescent boys grow taller, a study presented at ENDO 2016 has ...
However, the absolute risk for cardiovascular events with either agent in the trials was low—about 4.2% with aromatase inhibitors and 3.4% with tamoxifen—said the lead author of the study, Dr Eitan ...
Please provide your email address to receive an email when new articles are posted on . Bradley and colleagues performed a meta-analysis of data from four randomized trials — ABCSG 12, TEXT, SOFT and ...
There's new evidence that two inexpensive generic drugs can improve survival rates for women who develop breast cancer after menopause. In two large studies published Friday in The Lancet, a class of ...
Purpose. The clinical and economic benefits of aromatase inhibitor (AI) therapy in early-stage breast cancer are reviewed. Summary. AI therapy has become a standard of care for the treatment of most ...
Aromatase expression has been described in stromal cells of endometriosis, adenomyosis and endometrial cancer. We analyzed aromatase expression in a series of 23 low-grade endometrial stromal sarcomas ...
Aromatase inhibitors are a class of hormonal agents that form part of the therapy for some types of breast cancer. These agents are available as pills and may be started after initial surgery or ...
Please provide your email address to receive an email when new articles are posted on . Recent data from Washington University in St. Louis have shown that aromatase inhibitors can shrink tumors and ...
Aromatase inhibitors such as letrozole are used to treat some growth disorders. Since aromatase inhibitors suppress estrogen biosynthesis and stimulate secretion of gonadal androgens, these drugs ...
Every year, tens of thousands of breast cancer survivors are prescribed aromatase inhibitors—medications recommended for up to ten years to protect against a recurrence of the disease. But these drugs ...
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same ...
How Effective Is Dose-Intensive/Myeloablative Therapy Against Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Metastatic to Bone or Bone Marrow? The Memorial Sloan ...